Table 1. Review of publicly available endometriosis datasets.
| Number | Percentage | Datasets | |
|---|---|---|---|
| Endometrium only | 45 | 36.89 | Endometrial datasets |
| Tissue | 25 | 55.56 | GSE101176, GSE11768, GSE107469, GSE120103, GSE130028, GSE130435, GSE134052, GSE134056, GSE135485, GSE135640, GSE139954, GSE145702, GSE14808, GSE153739, GSE153740, GSE172172, GSE174305, GSE167946, GSE17504, GSE188915, GSE19834, GSE216255, GSE202571, GSE203191, GSE223817, GSE232713, GSE31683, GSE35287, GSE40007, GSE51981, GSE6364, GSE7305, GSE73622, GSE73950, GSE94414, GSE85701, GSE7846, GSE262037, GSE193928, GSE268541, GSE212787, GSE272606, GSE275002, E-MTAB-14039, E-MTAB-14058 |
| Cells | 20 | 44.44 | |
| Immortal cell line | 13 | 10.66 | Cell line datasets |
| 12Z | 7 | 53.85 | GSE114332, GSE68104, GSE86572, GSE97373, GSE261931, GSE184431, GSE152661, GSE157735, GSE174741, GSE190549, GSE202661, GSE210201, GSE279835 |
| EEC16 | 5 | 38.46 | |
| iHEECs | 1 | 7.69 | |
| Non-lesion endometriosis | 14 | 11.48 | Non-lesion endometriosis |
| Blood and blood vessels | 9 | 64.29 | GSE168214, GSE57832, GSE205494, GSE220787, GSE192636, E-MEXP-1251, GSE77182, GSE153813, GSE133867, GSE182983, GSE69310, GSE46735, GSE279435, GSE124010 |
| Reproductive tract | 5 | 35.71 | |
| Primary tissue culture | 17 | 13.93 | Primary culture datasets |
| Primary cells | 16 | 94.12 | GSE124010, GSE121406, GSE135122, GSE136412, GSE31515, GSE40186, GSE44207, GSE47361, GSE58178, GSE67524, GSE75427, GSE87810, GSE243158, GSE132464, GSE269530, GSE168902, GSE118928 |
| Primary organoids | 1 | 6.25 | |
| Endometrioma | 12 | 70.59 | |
| No phenotype listed | 5 | 29.41 | |
| Stromal | 16 | 94.12 | |
| Epithelial | 1 | 5.88 | |
| Without biological control | 3 | 17.65 | |
| With biological control | 14 | 82.35 | |
| Normal endometrium only | 6 | 42.86 | |
| Eutopic endometrium only | 5 | 35.71 | |
| Both eutopic and normal | 3 | 21.43 | |
| Additional controls | 0 | 0.00 | |
| Endometriosis tissue | 36 | 29.51 | Endometriosis tissue datasets |
| Endometrioma only | 19 | 52.78 | GSE279835, GSE11691, GSE197928, GSE12768, GSE141549, GSE15309, GSE157153, GSE16079, GSE179640, GSE185273, GSE196748, GSE201912, GSE213216, GSE226575, GSE230956, GSE23339, GSE239685, GSE246202, GSE25628, GSE26346, GSE37837, GSE5108, GSE56414, GSE57545, GSE71477, GSE7307, GSE86534, GSE99949, GSE229735, GSE105764, GSE248593, GSE281569, GSE247695, E-MTAB-694, GSE94414 |
| Superficial only | 1 | 2.78 | |
| Deep infiltrating only | 1 | 2.78 | |
| Peritoneal, unknown depth | 3 | 8.33 | |
| No phenotype listed | 4 | 11.11 | |
| Multiple phenotypes | 8 | 22.22 | |
| Without biological control | 0 | 0.00 | |
| With biological control | 36 | 100.00 | |
| Normal endometrium only | 3 | 8.33 | |
| Eutopic endometrium only | 13 | 36.11 | |
| Endometrium unknown source | 2 | 5.56 | |
| Both eutopic and normal | 2 | 5.56 | |
| Compared to EAOC | 6 | 16.67 | |
| Additional controls | 10 | 27.78 |
EAOC, endometriosis-associated ovarian cancer.
Full summary of the reviewed publicly available datasets, their biospecimens, and any associated publications can be found in Supplementary file 1.